Number of Clinical Trials 2006
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 โ
Where does your country rank? Pick it to see its position.
Related Health statistics
More โInteractive Map
Complete Data Rankings
- #1
United States
- #2
Germany
- #3
Canada
- #4
United Kingdom
- #5
France
- #6
Denmark
- #7
Australia
- #8
China
- #9
Netherlands
- #10
Japan
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #91
Sudan
- #90
Sri Lanka
- #89
Slovenia
- #88
Serbia
- #87
Senegal
- #86
Saudi Arabia
- #85
Rwanda
- #84
Romania
- #83
Puerto Rico
- #82
North Macedonia
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Ghana
In 2006, Ghana ranked #39 globally with a total of 6 clinical trials. This number is relatively modest compared to leading countries in clinical research, which often have hundreds or thousands of trials. Ghana's clinical trial activity is influenced by its growing healthcare sector and increasing international collaborations aimed at addressing local health challenges, particularly in infectious diseases.
Fiji
In 2006, Fiji ranked #60 globally with a total of 2 clinical trials. This number is notably low compared to neighboring countries, which often engage in more extensive clinical research activities. Factors contributing to this limited number include Fiji's smaller population and economic constraints, which can restrict investment in healthcare research and development.
Gabon
In 2006, Gabon ranked #54 globally with a total of 3 clinical trials. This number is significantly lower than the average for sub-Saharan Africa, where many countries engage in extensive clinical research. Gabon's limited infrastructure and smaller population may hinder the development of clinical trials, along with a focus on other health priorities such as infectious diseases and maternal health.
Central African Republic
In 2006, the Central African Republic ranked #70 globally with a total of 1 clinical trial. This figure is notably low compared to other countries in the region, reflecting a lack of infrastructure and investment in healthcare research. Contributing factors include ongoing political instability and limited access to medical resources, which hinder the countryโs ability to attract and conduct clinical research effectively.
Ecuador
Ecuador ranked #72 globally with a total of 1 clinical trial in 2006. This low number reflects a significant gap compared to regional leaders in South America, which typically have more robust clinical research infrastructures. Factors contributing to Ecuador's position include limited investment in healthcare research and a smaller population base, which can restrict the scale and scope of clinical trials.
Indonesia
In 2006, Indonesia ranked #49 globally with a total of 4 clinical trials. This figure is notably low compared to regional neighbors, indicating a significant gap in clinical research activity. Contributing factors include a developing healthcare infrastructure and limited investment in research and development, which hinder the country's ability to attract and conduct clinical trials effectively.
Czech Republic
The Czech Republic ranked #26 globally with a total of 14 clinical trials in 2006. This figure reflects a growing interest in clinical research, particularly in Central and Eastern Europe, where the region is increasingly recognized for its clinical trial capabilities. Factors contributing to this statistic include a well-educated workforce, a robust healthcare system, and favorable regulatory conditions that attract international pharmaceutical companies.
United Kingdom
The United Kingdom ranked #4 globally with 123 clinical trials in 2006. This figure is notable as it reflects a robust research environment, significantly higher than many neighboring countries. The UK's strong position is driven by its advanced healthcare system, prominent universities, and a favorable regulatory framework that supports clinical research.
Canada
In 2006, Canada ranked #3 globally with a total of 176 clinical trials. This number is significantly higher than many countries, highlighting Canada's strong position in clinical research, especially compared to the United States, which leads the world in this area. Factors contributing to Canada's success include a robust healthcare system, a diverse population that facilitates varied clinical studies, and supportive government policies that encourage medical research and innovation.
Cรดte d'Ivoire
Cรดte d'Ivoire ranked #75 globally with a total of 1 clinical trial in 2006. This figure is notably low compared to more developed countries, where the number of clinical trials often reaches into the hundreds or thousands. The limited number of clinical trials can be attributed to factors such as underdeveloped healthcare infrastructure and a lack of investment in research and development within the country.
Analysis & Context
In 2006, the United States led the world in the Number of Clinical Trials, conducting a total of 2187 trials. Globally, the range of clinical trials varied significantly, from a minimum of 1 to a maximum of 2187 across different countries. The global average number of clinical trials was 43.66, while the median stood at 5.00, highlighting a skewed distribution favoring a few leading nations.
Global Disparities in Clinical Trials
There is a stark contrast in the distribution of clinical trials across the globe, with the United States conducting a disproportionately high number of trials compared to other countries. This is followed by Germany with 199 trials and Canada with 176. The concentration of trials in these countries can be attributed to their advanced healthcare infrastructure, significant investment in research and development, and a strong pharmaceutical industry presence.
Conversely, several countries, including Tunisia, Sudan, and Sri Lanka, reported only 1 clinical trial each. These low numbers may reflect limited healthcare resources, less developed research facilities, and possibly lower prioritization of clinical research in national health agendas.
Economic and Policy Drivers
The concentration of clinical trials in wealthier nations can often be linked to economic factors and policy frameworks that encourage research. For instance, countries like the United Kingdom with 123 trials and France with 122 benefit from government policies that support innovation and provide incentives for pharmaceutical companies to conduct trials. Furthermore, these countries have well-established regulatory environments that facilitate the approval and monitoring of clinical trials.
In contrast, countries at the bottom of the list might lack such supportive frameworks or face bureaucratic hurdles that deter international and domestic investments in clinical research. For example, the presence of only 1 clinical trial in countries like Zimbabwe and Belarus may suggest regulatory challenges or economic constraints.
Regional Trends and Influences
Examining regional trends, we observe that Europe hosts several countries with high numbers of clinical trials, such as Germany, the United Kingdom, and France. This can be attributed to collaborative efforts within the European Union to promote research and share resources across borders. Similarly, Australia with 72 trials and Japan with 62 demonstrate strong regional capabilities in Asia-Pacific, driven by robust healthcare systems and a focus on medical innovation.
Meanwhile, the presence of 71 trials in China signals its growing role in global clinical research, supported by its burgeoning pharmaceutical industry and increasing investment in healthcare infrastructure.
Year-over-Year Changes and Trends
Analyzing year-over-year changes, the United States saw the largest increase in clinical trials, adding 463 trials, representing a 26.9% increase. This growth underscores the country's continuing dominance and investment in medical research. Other significant increases were seen in Germany with an additional 45 trials, marking a 29.2% rise, and Australia with a remarkable 132.3% increase, adding 41 trials.
However, not all countries experienced growth. Malawi saw a substantial decrease of 88.9%, losing 8 trials, which could indicate shifts in research focus or funding reallocations. Similarly, Taiwan and Portugal experienced reductions of 11.4% and 62.5% respectively, suggesting possible economic or policy changes affecting their research capacities.
Overall, the data from 2006 reveals a landscape where a few nations dominate the clinical trial arena, driven by economic strength and supportive policies, while others lag, highlighting the global disparities in medical research capabilities.
Frequently Asked Questions About Number of Clinical Trials in 2006
Which country conducted the most clinical trials in 2006?
The United States conducted the most clinical trials in 2006, with a total of 2,187 trials.
What was the average number of clinical trials conducted per country in 2006?
The average number of clinical trials conducted per country in 2006 was 43.66.
Which country conducted the fewest clinical trials in 2006?
Tunisia conducted the fewest clinical trials in 2006, with only 1 trial.
What was the median number of clinical trials conducted by countries in 2006?
The median number of clinical trials conducted by countries in 2006 was 5.
Can you list the top 3 countries with the highest number of clinical trials in 2006?
The top 3 countries with the highest number of clinical trials in 2006 were the United States with 2,187 trials, Germany with 199 trials, and Canada with 176 trials.
How many countries conducted only 1 clinical trial in 2006?
There were 10 countries that conducted only 1 clinical trial in 2006, including Tunisia, Sudan, and Sri Lanka.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2006. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2006
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
โบEmbed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.